Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.
Statement re Nomad and Update Avid Holdings plc Update and Resignation of NOMAD On 14 November 2008, the Company requested a suspension of its shares pending clarification of the Company's financial position. On 4 December 2008, the Company further announced that Electro-mec (Reading) Limited, a subsidiary company, had been placed into administration. The Directors now announce that Alpha Anodising Limited and the tooling and precision engineering divisions of Electro-mec (Reading) Limited and Electropac and its patents have now been sold. The Directors deeply regret that there will be insufficient recoveries for a payout to shareholders. Avid Holdings plc, the non trading holding company is being wound up and the relevant petition is currently being prepared. The non-executive directors, Michael Walter, David Walton Masters and Bob Dover have all resigned. The executive directors, Jonathan Bobbett and Jonathan Neal have agreed to remain to assist with winding up of the Company. Further, the Company's NOMAD has given notice to resign with immediate effect. In accordance with the AIM Rules for Companies unless the Company appoints a replacement NOMAD the trading facility in the Company's shares will be cancelled with effect from 7.00am on 14 April 2009. For further information contact: Jonathan Bobbett, Chief Executive Avid Holdings plc +44 (0) 7976571246 Ross Andrews, Nominated Adviser Zeus Capital Ltd +44 (0) 161 831 1512 vendor
Popular amidst light trading (Irish Times), http://www.irishtimes.com/business/markets/1230581468987.html Irish government rescue (Filipino interest), http://www.bworldonline.com/BW122408/content.php?id=026 Note: A number of shortsellers are trying to keep this down; otherwise, the way seems to be up until true value reached, given the solid state backing.
It appears Bayer simply felt jilted by Tuesday's Monsanto deal as they had expressed interest in that as well in September (but not hammered a deal), so in my view the termination does not reflect badly on the Myconet product or PHC the maker/company as such but opens the field for negotiation with other possible suitors with possibly better returns. This is my deduction from talking to the PR firm and reading a Reuters story, excerpt: "Separately, Plant Health Care said it was in talks with a number of parties including major agrichemical companies on possible collaboration to further develop and commercialise Myconate, and it expected to conclude another significant development deal in 2009. In September, Bayer CropScience announced a long-term licence agreement to use Plant Health Care's harpin genes in brassica oilseeds, a key ingredient in vegetable oils. Plant Health Care said on Tuesday it had agreed with U.S. biotech company Monsanto Co (MON.N: Quote, Profile, Research) on the commercialisation of a harpin-based seed treatment for row crops and vegetables." Source: http://uk.reuters.com/article/companyOutlooksNews/idUKBNG7117620081218 Therefore this will rally again, as there are plenty of buyers at between 200p and 260p, and possibly higher, who are confident of returns soon, if not in the medium and long term. So I have cashed in taken these at a bargain.
What's happening with their 2008 results/report? http://www.second2digital.com/spiritel/spi004/invest_report.htm
Perhaps their credit negotiations could be better with today rate cut. Best to click 'Statement re Share Price Movement' link at http://www.londonstockexchange.com/en-gb/pricesnews/prices/system/detailedprices.htm?ti=AVD "the Company is continuing to seek short-term finance and will make a further announcement in due course."